Milestone Scientific shares are trading higher after the company announced the Medicare price assignment for its CompuFlo Epidural System.
Portfolio Pulse from Benzinga Newsdesk
Milestone Scientific shares are trading higher following the announcement of Medicare price assignment for its CompuFlo Epidural System.
July 23, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Milestone Scientific shares are experiencing an upward trend after the company announced that Medicare has assigned a price for its CompuFlo Epidural System.
The Medicare price assignment for the CompuFlo Epidural System is a significant milestone for Milestone Scientific, likely leading to increased adoption and revenue. This positive development is driving the stock price higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100